Publisher: New York Law Publishing Co.
Frequency: Monthly (12 issues)
Publisher's Price: $95/year
The withdrawal of the diet drugs fenfluramine and dexfenfluramine has spawned thousands of state and federal lawsuits. This newsletter combines analysis from both plaintiff and defense perspectives with the important medical expertise you need to make sense of this important controversy. Keep up to date on the state of the evidence, the status of the multi-district litigation, the latest state court rulings, and the most recent science news in the United States as well as Europe. What have the FDA and NIH said about these drugs, for which some 14 million prescriptions were written? What have the drug companies learned, and for how long have they known it? How can you best identify appropriate defendants? The Fen-Phen Litigation Strategist is must reading for practitioners in the product liability and medical malpractice areas who want the latest legal and medical news.
Product
Merchant
Merchant Promotions
Shipping
Price
Purchase
Monthly (12 issues)
Security | Privacy Policy | Feedback | LawBuys in the News
Email: Administrator@LawBuys.com